You've witnessed the thousands of success stories—real people beating cancer with ivermectin and fenbendazole when all other treatments have failed. Yet the heartbreak of those who didn’t survive despite trying these hopeful alternatives strengthens your resolve. This petition aims to foster clinical trials that can transform these anecdotes into hard, irrefutable data, guaranteeing that hospice patients in their fight against terminal cancer receive proven treatment options.

Ivermectin and fenbendazole have shown potential in shrinking tumors and fighting cancer, as evidenced by notable cases like that of Joe Tippens. Emerging research, dated 9/19/24, supports the efficacy of these drugs, yet their affordability makes them an improbable candidate for Big Pharma's funding—especially when profits from expensive, patented treatments are at stake. This is why we implore institutions such as the National Cancer Institute (NCI) and leading cancer centers to commence formal trials, including innovative approaches such as intravenous (IV) ivermectin drips.

For too long, affordability has taken a backseat in the race for effective cancer treatments. Every person battling cancer deserves access to every possible lifeline, especially when it comes to hospice patients with limited options. Initiating these trials is not asking for a miracle; it's about opening doors to potentially life-saving treatments that are readily accessible but underexplored due to financial biases in research funding.

Your signature can compel change. Stand with us in urging the NCI and other leaders in oncological research to prioritize the needs of cancer patients over pharmaceutical profits. Together, let's ensure that every patient gets a real chance at survival, fueled by groundbreaking research and equitable treatment options. Sign this petition to give hope and a fighting chance to those in hospice care.